{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:14:55Z","timestamp":1697382895424},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1016\/s0145-2126(03)00004-3","type":"journal-article","created":{"date-parts":[[2003,3,25]],"date-time":"2003-03-25T23:24:25Z","timestamp":1048634665000},"page":"853-857","source":"Crossref","is-referenced-by-count":6,"title":["Chronic lymphocytic leukemia (B-CLL) occurring with human immunodeficiency virus (HIV) infection: implications"],"prefix":"10.1016","volume":"27","author":[{"given":"Farhad","family":"Ravandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Ridgeway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Pursell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0145-2126(03)00004-3_BIB1","first-page":"11","article-title":"Molecular biology of chronic lymphocytic leukemia","volume":"25","author":"Reed","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB2","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig (VH) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB5","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl. J. Med."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB6","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB7","first-page":"3","article-title":"Molecular biology of chronic lymphocytic leukemia: implications for therapy","volume":"35","author":"Reed","year":"1998","journal-title":"Semin. Hematol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB8","first-page":"104","article-title":"Immunogenetic therapy for B-cell malignancies","volume":"27","author":"Kipps","year":"2000","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB9","unstructured":"Ghia P, Caligaris-Cappio F. The origin and nature of the chronic lymphocytic leukemia lymphocyte. In: Cheson BD, editor, Chronic lymphoid leukemias. 2nd ed. New York, Basel: Marcl Dekker; 2001. p. 63\u201380."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB10","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood.V62.6.1289.1289","article-title":"Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia","volume":"62","author":"Pizzolo","year":"1983","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.1999.01642.x","article-title":"Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia","volume":"106","author":"Kitada","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB12","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1182\/blood.V92.3.990","article-title":"Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells","volume":"92","author":"Romano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","article-title":"CD95\u2019s deadly mission in the immune system","volume":"407","author":"Krammer","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF02787206","article-title":"Apoptosis in B-chronic lymphocytic leukaemia","volume":"15","author":"Osorio","year":"1998","journal-title":"Med. Oncol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2141.1997.422688.x","article-title":"Role of the CD40 and CD95 (APO-1\/Fas) antigens in the apoptosis of human B-cell malignancies","volume":"97","author":"Wang","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB16","first-page":"1227","article-title":"Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia","volume":"9","author":"Panayiotidis","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB17","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood.V95.12.3853","article-title":"CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes","volume":"95","author":"Chu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/1566524013363320","article-title":"How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors","volume":"1","author":"Cloyd","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB19","doi-asserted-by":"crossref","unstructured":"Levine AM, Scadden DT, Zaia JA, Krishnan A. Hematologic aspects of HIV\/AIDS. Hematology (Am Soc Hematol Educ Prog) 2001;463\u201378.","DOI":"10.1182\/asheducation-2001.1.463"},{"key":"10.1016\/S0145-2126(03)00004-3_BIB20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB21","unstructured":"Klein G, Klein E. Epstein-Barr virus and human lymphomas. In: Canellos GP, Lister TA, Sklar JL, editors. The lymphomas. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: Saunders; 1998. p. 63\u201373."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB22","first-page":"390","article-title":"The epidemiology of acquired immunodeficiency syndrome malignancies","volume":"27","author":"Goedert","year":"2000","journal-title":"Semin. Oncol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB23","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-108-5-744","article-title":"Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981\u20131986)","volume":"108","author":"Knowles","year":"1988","journal-title":"Ann. Intern Med."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-9343(87)90435-9","article-title":"Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors","volume":"82","author":"Kaplan","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB25","first-page":"130","article-title":"Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria","volume":"44","author":"Analo","year":"1998","journal-title":"Cent. Afr. J. Med."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF00237104","article-title":"Epidemiological aspects of HTLV-III infection in Italy","volume":"1","author":"Rossi","year":"1985","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/S0145-2126(03)00004-3_BIB27","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/cncr.10368","article-title":"Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection","volume":"94","author":"Levine","year":"2002","journal-title":"Cancer"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212603000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T07:14:41Z","timestamp":1584515681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212603000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S0145212603000043"],"URL":"https:\/\/doi.org\/10.1016\/s0145-2126(03)00004-3","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}